Table 3.
Patient characteristics for BAL ELISA assay
Category | Benign | ADC | SQCC | SCLC | |
---|---|---|---|---|---|
Gender | F | 3 | 11 | 5 | 2 |
M | 3 | 7 | 4 | 4 | |
Race | African American | 2 | 2 | 3 | 3 |
Caucasian | 4 | 15 | 4 | 3 | |
Other | 0 | 1 | 2 | 0 | |
Smoking status | Current smoker | 2 | 5 | 3 | 2 |
Ex-smoker | 2 | 8 | 2 | 4 | |
Never smoker | 1 | 2 | 0 | 0 | |
Unknown | 1 | 3 | 4 | 0 | |
Median age at diagnosis | 54 yr | 63.5yr | 68.5yr | 70yr | |
Range | 18–85 yr | 51–83 yr | 55–85yr | 65–73yr | |
Pathological stage | pT1 | N/A | 3 | 1 | 0 |
pT2 | N/A | 4 | 2 | 2 | |
pT3 | N/A | 5 | 1 | 2 | |
pT4 | N/A | 2 | 1 | 0 | |
Unknown | N/A | 4 | 4 | 2 | |
Total number of samples | 6 | 18 | 9 | 6 |
ADC:adenocarcinoma
SQCC: squamous cell carcinoma
SCLC: small cell lung carcinoma
yr: years
pT: pathological stage
N/A: not applicable.